PET imaging analysis with 64cu in disulfiram treatment for aberrant copper biodistribution in menkes disease mouse model

Journal of Nuclear Medicine

Volumn 55, Issue 5, 2014, Pages 845-851

  Nomura, Shiho ^a   Nozaki, Satoshi ^b   Hamazaki, Takashi ^a   Takeda, Taisuke ^a   Ninomiya, Eiichi ^a   Kudo, Satoshi ^a   Hayashinaka, Emi ^b   Wada, Yasuhiro ^b   Hiroki, Tomoko ^c   Fujisawa, Chie ^c   Kodama, Hiroko ^c   Shintaku, Haruo ^a   Watanabe, Yasuyoshi ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Copper; D penicillamine; Disulfiram; Menkes disease; PET

Indexed keywords

COPPER; COPPER 64; COPPER CHLORIDE; DISULFIRAM; PENICILLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; CONTROLLED STUDY; DRUG MECHANISM; KIDNEY MEDULLA; MENKES SYNDROME; MOLECULAR IMAGING; MOUSE; NONHUMAN; PARENCHYMA; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; URINARY EXCRETION; WILD TYPE;

COPPER; D-PENICILLAMINE; DISULFIRAM; MENKES DISEASE; PET;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CHELATING AGENTS; COPPER; COPPER RADIOISOTOPES; DISEASE MODELS, ANIMAL; DISULFIRAM; GAMMA RAYS; KIDNEY; LIVER; MENKES KINKY HAIR SYNDROME; MICE; MICE, INBRED C3H; MUTATION; PENICILLAMINE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84901296946     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.131797     Document Type: Article

References (31)

1. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet. 1993;3:7-13.
2. Kodama H, Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr Int. 1999;41:430-435.
3. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87:1011-1046.
4. Kodama H, Abe T, Takama M, Takahashi I, Kodama M, Nishimura M. Histochemical localization of copper in the intestine and kidney of macular mice: light and electron microscopic study. J Histochem Cytochem. 1993;41:1529-1535.
5. Kodama H, Meguro Y, Abe T, et al. Genetic expression of Menkes disease in cultured astrocytes of the macular mouse. J Inherit Metab Dis. 1991;14:896-901.
6. Shiraishi N, Aono K, Taguchi T. Copper metabolism in the macular mutantmouse: an animal model of Menkes's kinky-hair disease. Biol Neonate. 1988;54:173-180.
7. Murata Y, Kodama H, Abe T, et al. Mutation analysis and expression of the mottled gene in the macular mouse model of Menkes disease. Pediatr Res. 1997;42:436-442.
8. Kodama H, Murata Y, Kobayashi M. Clinical manifestations and treatment of Menkes disease and its variants. Pediatr Int. 1999;41:423-429.
9. Meguro Y, Kodama H, Abe T, Kobayashi S, Kodama Y, Nishimura M. Changes of copper level and cytochrome c oxidase activity in the macular mouse with age. Brain Dev. 1991;13:184-186.
10. Kreuder J, Otten A, Fuder H, et al. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease. Eur J Pediatr. 1993;152:828-832.
11. Sarkar B, Lingertat-Walsh K, Clarke JT. Copper-histidine therapy for Menkes disease. J Pediatr. 1993;123:828-830.
12. Wenk G, Suzuki K. The effect of copper supplementation on the concentration of copper in the brain of the brindled mouse. Biochem J. 1982;205:485-487.
13. Kaler SG, Das S, Levinson B, et al. Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small in-frame deletion. Biochem Mol Med. 1996;57:37-46.
14. Christodoulou J, Danks DM, Sarkar B, et al. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet. 1998;76:154-164.
15. Kodama H, Okabe I, Kihara A, Mori Y, Okaniwa M. Renal tubular function of patients with classical Menkes disease. J Inherit Metab Dis. 1992;15:157-158.
16. Lenartowicz M, Kowal M, Buda-Lewandowska D, Styrna J. Pathological structure of the kidney from adult mice with mosaic mutation. J Inherit Metab Dis. 2002;25:647-659.
17. Lenartowicz M, Windak R, Tylko G, Kowal M, Styrna J. Effects of copper supplementation on the structure and content of elements in kidneys of mosaic mutant mice. Biol Trace Elem Res. 2010;136:204-220.
18. Cai L, Li XK, Song Y, Cherian MG. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem. 2005;12:2753-2763.
19. Lutsenko S, Petris MJ. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches. J Membr Biol. 2003;191:1-12.
20. Kodama H, Sato E, Gu YH, Shiga K, Fujisawa C, Kozuma T. Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease. J Inherit Metab Dis. 2005;28:971-978.
21. MunakataM, Kodama H, Fujisawa C, et al. Copper-trafficking efficacy of copperpyruvaldehyde bis(N4-methylthiosemicarbazone) on the macular mouse, an animal model of Menkes disease. Pediatr Res. 2012;72:270-276.
22. Szerdahelyi P, Kása P. Regional differences in the uptake of exogenous copper into rat brain after acute treatment with sodium diethyldithiocarbamate: a histochemical and atomic absorption spectrophotometric study. Histochemistry. 1987;86: 627-632.
23. Aaseth J, Søli NE, Førre O. Increased brain uptake of copper and zinc in mice caused by diethyldithiocarbamate. Acta Pharmacol Toxicol (Copenh). 1979;45:41-44.
24. Johansson B, Stankiewicz Z. Bis-(diethyldithiocarbamato) copper complex: a new metabolite of disulfiram? Biochem Pharmacol. 1985;34:2989-2991.
25. Staud F, Nishikawa M, Morimoto K, Takakura Y, Hashida M. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I: effect of labeling on distribution and excretion of radioactivity in rats. J Pharm Sci. 1999;88:577-585.
26. Mizuma H, Shukuri M, Hayashi T, Watanabe Y, Onoe H. Establishment of in vivo brain imaging method in conscious mice. J Nucl Med. 2010;51:1068-1075.
27. Yamashita S, Takashima T, Kataoka M, et al. PET imaging of the gastrointestinal absorption of orally administered drugs in conscious and anesthetized rats. J Nucl Med. 2011;52:249-256.
28. Takashima T, Wu C, Takashima-Hirano M, et al. Evaluation of breast cancer resistance protein function in hepatobiliary and renal excretion using PET with 11C-SC-62807. J Nucl Med. 2013;54:267-276.
29. Yamato M, Kataoka Y, Mizuma H, Wada Y, Watanabe Y. PET and macro-and microautoradiographic studies combined with immunohistochemistry for monitoring rat intestinal ulceration and healing processes. J Nucl Med. 2009;50:266-273.
30. Bhadhprasit W, Kodama H, Fujisawa C, Hiroki T, Ogawa E. Effect of copper and disulfiram combination therapy on the macular mouse, a model of Menkes disease. J Trace Elem Med Biol. 2012;26:105-108.
31. Martin SM, O'Donnell RT, Kukis DL, et al. Imaging and pharmacokinetics of 64Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts. Mol Imaging Biol. 2009;11:79-87.